STK3 and ovarian cancer: Low STK3 expression was associated with a worse prognosis in ovarian cancer [29], and its restoration significantly inhibited cell proliferation, apoptosis, and migration in different cancers in vitro and suppressed tumour growth in vivo [30–32].